ANNOUNCEMENT 14 Dec 2015

The Brazilian government-funded Company of Innovation and Research (FINEP) approved a BRL 182.5 million loan to Orygen Biotecnologia S.A.

NUMBER OF INTERVENTIONS

1

  • 1 harmful
  • 0 neutral
  • 0 liberalising

SOURCE

Brazilian Company of Innovation and Research. Empresa Brasileira de Inovaçao e Pesquisa. Projetos contratados e valores liberados. Retrieved on 02/05/2018. Available at: http://finep.gov.br/acesso-a-informacao-externo/transparencia/projetos-contratados-e-valores-liberados

Brazilian Company of Innovation and Research. Empresa Brasileira de Inovaçao e Pesquisa. Financiamento Reembolsável. Available at: http://finep.gov.br/component/content/article/120-apoio-e-financiamento/tipos-de-apoio/financiamento-reembolsavel/42-financiamento-reembolsavel

Inception date: 14 Dec 2015 | Removal date: 14 Dec 2018

State loan

On 14 December 2015, the Brazilian Company of Innovation and Research (FINEP) announced the approval of BRL 182.5 million (USD 46.8 million) loan allocated to the local pharmaceutical company Orygen Biotecnologia S.A. The objective of these resources is to develop new biological medicines.

The repayment deadline for the credit has been set to 14 December 2018.


FINEP lending
The resources enclosed on the programs managed by FINEP are limited to Brazilian companies and seek to boost the national and international competitiveness of these businesses.

The interest rates set on the credit lines are composed of the long-term interest rate (TJLP) plus a supplement ranging between 1.5% and 7%, depending on the credit line and the repayment period.

AFFECTED SECTORS

 

AFFECTED PRODUCTS